AI Infrastructure Stocks | Data Center & Cloud Plays
Nvidia's recent memo addressing criticism has cast a spotlight on the sustainability of the AI boom, causing investor uncertainty. This creates a potential opening for companies in adjacent, more stable sectors like data center infrastructure and enterprise cloud services that support the AI ecosystem.
Your Basket's Financial Footprint
This basket's total market capitalisation is $208.97B and is anchored by several very large-cap constituents, giving it a predominantly large-cap profile.
- Large-cap dominance suggests generally lower volatility and more market-like performance, offering relatively stable returns versus small-cap baskets.
- Treat this basket as a core portfolio holding for broad exposure, not as a short-term speculative trade.
- Expect gradual, long-term appreciation rather than rapid gains; growth is likely steady but not explosive.
DLR: $54.59B
NET: $69.00B
STRL: $10.44B
- Other
About This Group of Stocks
Our Expert Thinking
With scrutiny mounting on pure-play AI companies following Nvidia's recent memo addressing criticism, we're focusing on the essential infrastructure that powers the AI revolution. These companies provide the foundational data centers, cloud services, and digital infrastructure that AI applications depend on, offering potentially more stable exposure to AI growth.
What You Need to Know
This group represents the backbone of the digital economy - from data center operators to cloud service providers and enterprise software companies. These businesses benefit from the long-term demand for data management and computing power, regardless of short-term AI market volatility. They offer a more defensive approach to AI investment.
Why These Stocks
Each company was handpicked by professional analysts for their critical role in supporting AI and cloud computing infrastructure. As investors seek more tangible, stable investments amid AI sector uncertainty, these foundational technology providers could benefit from their essential position in the digital value chain.
Why You'll Want to Watch These Stocks
The Infrastructure Gold Rush
As AI scrutiny intensifies, smart money is shifting to the companies that build and maintain the essential infrastructure powering the entire digital revolution. These are the picks and shovels of the AI boom.
Defensive AI Exposure
Whilst pure-play AI stocks face volatility, these foundational companies offer more stable exposure to AI growth through essential data centres, cloud services, and enterprise infrastructure that won't disappear overnight.
Future-Proof Investments
Whether AI soars or faces setbacks, the demand for data storage, cloud computing, and digital infrastructure will only grow. These companies are positioned at the centre of our increasingly digital world.
Get the full story on this Basket. Read our detailed article on its risks and potential.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Railroad Investment: Beyond the $85 Billion Merger
Union Pacific and Norfolk Southern are seeking to merge, creating America's first transcontinental railroad. This landmark consolidation could drive significant investment into rail infrastructure and technology, creating opportunities for companies that support and equip the freight rail industry.
Oracle TikTok Deal May Boost Stocks in 2025
TikTok has finalized the sale of its U.S. operations to an investor group including Oracle, resolving national security concerns and securing its future in the American market. This development creates opportunities for companies in the digital advertising, social commerce, and creator economy sectors that can now capitalize on the platform's stabilized presence and massive user base.
Pharma Reshoring Explained | Manufacturing Investment
Major pharmaceutical firms have signed agreements with the U.S. government to lower drug prices in exchange for tariff exemptions and other concessions. This move is expected to drive over $150 billion in new domestic R&D and manufacturing investments, creating opportunities for U.S.-based life sciences and industrial supply chain companies.